(Reuters) - An epilepsy treatment from GW Pharmaceuticals Plc on Monday secured an approval from the U.S. Food and Drug Administration, becoming the first cannabis-based drug to be approved in the country.
from Reuters: Health News https://ift.tt/2Ki33mh
No comments:
Post a Comment